Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
DAVENPORT, Iowa, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Lee Enterprises, Incorporated (NASDAQ: LEE) (the “Company”), a leading provider of trusted local news, information, and digital marketing services,...
-
Reykjavík, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Amaroq Ltd.(“Amaroq” or the “Company”) Total Voting Rights and Notification of Transactions of a Persons Discharging Managerial Responsibilities...
-
HONG KONG, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, today announced that it...
-
Aktieägarna i Karolinska Development AB (publ), org.nr 556707-5048, (“Karolinska Development” eller “Bolaget”), kallas till extra bolagsstämma torsdagen den 8 januari 2026 kl. 10.00 hos Cirio...
-
The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, (“Karolinska Development” or the “Company”) are invited to the Extraordinary General Meeting (“EGM”), on Thursday January 8,...
-
Detta är information som emittenten är skyldig att offentliggöra enligt 15 kap. 8 § lagen (2007:528) om värdepappersmarknaden. Stockholm, 2 december 2025 - Virtune meddelar att från och med den 4...
-
This information is such that the issuer is obliged to make public pursuant to Chapter 15, Section 8 of the Swedish Securities Market Act (2007:528). Stockholm, 2 December 2025 – Virtune announces...
-
Egan-Jones Cites Cannae’s “Financial Underperformance”, “Misaligned Capital Allocation”, “Lack of Credible Shareholder Distribution Plan” and “Governance Concerns” in Joining ISS and Glass Lewis in...
-
På den ekstraordinære generalforsamling i Aktieselskabet Nordfyns Bank (”Nordfyns Bank”), der blev afholdt i dag den 1. december 2025, blev følgende forslag vedtaget: Gennemførelse af fusionen mellem...
-
BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology company dedicated to developing...